Organon & Co.
For the period ended Mar 31, 2026. Filed May 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 4, 2026
OGN$13.85-0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(Unaudited, $ in millions except shares in thousands and per share amounts)
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $1,116 | $574 |
| Accounts receivable (net of allowance for doubtful accounts of $14 in 2026 and $12 in 2025) | 1,384 | 1,331 |
| Inventories (excludes inventories of $252 in 2026 and $236 in 2025 classified in Other assets) | 1,373 | 1,406 |
| Other current assets | 1,059 | 1,033 |
| Assets held for sale | — | 8 |
| Total Current Assets | 4,932 | 4,352 |
| Property, plant and equipment, net | 1,279 | 1,303 |
| Goodwill | 4,153 | 4,153 |
| Intangibles, net | 1,099 | 1,130 |
| Other assets | 1,533 | 1,539 |
| Noncurrent assets held for sale | — | 390 |
| Total Assets | $12,996 | $12,867 |
| Liabilities and Equity | ||
| Current Liabilities: | ||
| Current portion of long-term debt and short-term borrowings | $16 | $16 |
| Trade accounts payable | 983 | 952 |
| Accrued and other current liabilities | 1,424 | 1,335 |
| Income taxes payable | 77 | 85 |
| Liabilities held for sale | — | 2 |
| Total Current Liabilities | 2,500 | 2,390 |
| Long-term debt | 8,553 | 8,628 |
| Deferred income taxes | 56 | 57 |
| Other noncurrent liabilities | 984 | 1,008 |
| Noncurrent liabilities held for sale | — | 32 |
| Total Liabilities | 12,093 | 12,115 |
| Contingencies (Note 15) | ||
| Organon & Co. Stockholders’ Equity: | ||
| Common stock, $0.01 par valueAuthorized - 500,000Issued and outstanding - 262,649 in 2026 and 260,316 in 2025 | 3 | 3 |
| Additional paid-in capital | 186 | 167 |
| Retained earnings | 1,253 | 1,109 |
| Accumulated other comprehensive loss | (539) | (527) |
| Total Stockholders’ Equity | 903 | 752 |
| Total Liabilities and Stockholders’ Equity | $12,996 | $12,867 |
-5-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.